FDA approves Synribo for chronic myelogenous leukemia
On Oct. 26, the U.S. Food and Drug Administration (FDA) approved Synribo (omacetaxine mepesuccinate) for the treatment of adults with chronic myelogenous leukemia. Synribo…
Oncology
Study: Online prostate cancer information may be hard for patients to understand
Although experts recommend that patient-education materials be written at the fourth-through-sixth grade level, a study published online by the Journal of Urology found that…
Putting Evidence Into Practice: Cognitive impairment
The latest in a series of articles on managing cancer-related symptoms from the Oncology Nursing Society.
The ethical will: A loving legacy
An ethical will serves as a vehicle for distilling a lifetime of wisdom and relaying messages of hope and love.
FDA approves Marqibo for rare type of leukemia
On Aug. 9, the U.S. Food and Drug Administration (FDA) approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome negative (Ph-)…
Study: Daily aspirin use lowers cancer mortality
Recent daily aspirin use is associated with lower cancer mortality but the size of the effect may be smaller than what was observed in…
Putting Evidence Into Practice: Skin reactions
The latest in a series of articles on managing cancer-related symptoms from the Oncology Nursing Society.
Anastrozole and fulvestrant combination effective in metastatic breast cancer
The combination of anastrozole and fulvestrant was more effective than anastrozole alone or sequential anastrozole and fulvestrant for the treatment of hormone receptor-positive metastatic…
Study: Serious mental illness increases cancer risk
The total cancer incidence in adults with schizophrenia or bipolar disorder was 2.6 times higher than the general population, according to a study of…
The nurse’s role in preventing cervical cancer: A cultural framework
A culturally appropriate framework can help nurses promote acceptance of the human papillomavirus vaccine.
Managing end-of-life symptoms
For patients nearing death, palliative care can enhance quality of life by easing pain and other symptoms, improving sleep, and reducing fatigue. Managing end-of-life…
FDA approves Perjeta for late-stage breast cancer
On June 8, the U.S. Food and Drug Administration (FDA) approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive late-stage breast…
FDA approves Synribo for chronic myelogenous leukemia
On Oct. 26, the U.S. Food and Drug Administration (FDA) approved Synribo (omacetaxine mepesuccinate) for the treatment of adults with chronic myelogenous…
Study: Online prostate cancer information may be hard for patients to understand
Although experts recommend that patient-education materials be written at the fourth-through-sixth grade level, a study published online by the Journal of Urology…
Putting Evidence Into Practice: Cognitive impairment
The latest in a series of articles on managing cancer-related symptoms from the Oncology Nursing Society.
The ethical will: A loving legacy
An ethical will serves as a vehicle for distilling a lifetime of wisdom and relaying messages of hope and love.
FDA approves Marqibo for rare type of leukemia
On Aug. 9, the U.S. Food and Drug Administration (FDA) approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome…
Study: Daily aspirin use lowers cancer mortality
Recent daily aspirin use is associated with lower cancer mortality but the size of the effect may be smaller than what was…
Putting Evidence Into Practice: Skin reactions
The latest in a series of articles on managing cancer-related symptoms from the Oncology Nursing Society.
Anastrozole and fulvestrant combination effective in metastatic breast cancer
The combination of anastrozole and fulvestrant was more effective than anastrozole alone or sequential anastrozole and fulvestrant for the treatment of hormone…
Study: Serious mental illness increases cancer risk
The total cancer incidence in adults with schizophrenia or bipolar disorder was 2.6 times higher than the general population, according to a…
The nurse’s role in preventing cervical cancer: A cultural framework
A culturally appropriate framework can help nurses promote acceptance of the human papillomavirus vaccine.
Managing end-of-life symptoms
For patients nearing death, palliative care can enhance quality of life by easing pain and other symptoms, improving sleep, and reducing fatigue.…
FDA approves Perjeta for late-stage breast cancer
On June 8, the U.S. Food and Drug Administration (FDA) approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive…